| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 06/30/2004 | CN1509271A 4-(phenyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for treatment of pain anxiety or gastrointestinal disorders |
| 06/30/2004 | CN1509196A 4(2-butylamino)-2,7-dimethyl-8-(2-methyl(-6-methoxyp-3-yl)pyrazolo-[1,5-A]-1,3,5-triazine as corticotropin releasing factor receptor |
| 06/30/2004 | CN1509188A Immunoconjugates made of egg-yolk antibiodies (IGY), production and use thereof in diagnoses and therapy |
| 06/30/2004 | CN1508250A Malignant malarial parasite msra-2 gene, protein product and use thereof |
| 06/30/2004 | CN1508155A Anti CD52 monoclonal antibody, coding sequence and use thereof |
| 06/30/2004 | CN1507904A Medicine for increasing organism immunological functioning and preparing method thereof |
| 06/30/2004 | CN1507880A Medicinal composition for treating rheumatoid |
| 06/30/2004 | CN1507868A Desloratadine dry-mixed suspensoid and preparing method thereof |
| 06/30/2004 | CN1155617C Novel peptides for use in treatment of t-cell mediated cartilage destruction in autoimmune diseases |
| 06/30/2004 | CN1155599C Tricyclic triazolobenzazepine derivatives, process for producing same, and antiallergic agent |
| 06/30/2004 | CN1155571C Gamma-glutamyl and beta-aspartyl containing immunomodulator compounds and methods therewith |
| 06/30/2004 | CN1155391C Novel immunosuppressants |
| 06/30/2004 | CN1155381C New pharmaceutical use of sinomenine |
| 06/30/2004 | CN1155374C Novel biological activity of proglumide |
| 06/30/2004 | CN1155369C Modified release oral pharmaceutical composition contg. 5-ASA and method for treatment of bowel diseases |
| 06/29/2004 | US6756481 IL-23 receptor binding compositions |
| 06/29/2004 | US6756480 Modulators of receptors for parathyroid hormone and parathyroid hormone-related protein |
| 06/29/2004 | US6756409 For therapy and prophylaxis of pain and/or neurodegenerative disorders |
| 06/29/2004 | US6756385 Imidazole derivatives |
| 06/29/2004 | US6756382 Amide substituted imidazoquinolines |
| 06/29/2004 | US6756381 A purified antitumor agent is crystallized from acetone or dichloromethane |
| 06/29/2004 | US6756380 5-phenyl-pyrimidine derivatives |
| 06/29/2004 | US6756376 Preventing fatty acid release |
| 06/29/2004 | US6756372 For therapy of autoimmune diseases, alzheimer's disease, atherosclerosis, osteoporosis, rheumatoid arthritis, systemic lupus erythematosus, crohn's disease, ulcerative colitis, multiple sclerosis, guillain-barre syndrome, psoriasis |
| 06/29/2004 | US6756371 Morpholino or thiomorpholino derivatives; respiratory system disorders |
| 06/29/2004 | US6756044 Heightening response of immune effector cells |
| 06/29/2004 | US6756041 Process for preparing conjugate vaccines including free protein and the conjugate vaccines, immunogens, and immunogenic reagents produced by this process |
| 06/29/2004 | CA2296726C Combination therapy |
| 06/29/2004 | CA2263913C Substituted 6,6-hetero-bicyclic derivatives |
| 06/29/2004 | CA2135192C Vaccinal fluid water-in-oil emulsions containing a metabolizable oil |
| 06/29/2004 | CA2105215C Novel oxazolidines |
| 06/24/2004 | WO2004052888A2 Tropane esters and methods for producing and using them |
| 06/24/2004 | WO2004052863A1 Anti-inflammatory agent |
| 06/24/2004 | WO2004052862A1 Nitrogen-containing heterocyclic compounds and medicinal use thereof |
| 06/24/2004 | WO2004052847A2 Tricyclic steroid hormone nuclear receptor modulators |
| 06/24/2004 | WO2004052462A1 Composition comprising lactobacilli or bifidobacteria and use thereof |
| 06/24/2004 | WO2004052365A2 Inhibition of inflamation using alpha 7 receptor-binding cholinergic agonists |
| 06/24/2004 | WO2004052276A2 Compositions and methods for the therapy and diagnosis of prostate cancer |
| 06/24/2004 | WO2004041862A3 Single domain antibodies directed against tumour necrosis factor-alpha and uses therefor |
| 06/24/2004 | WO2004024060A3 Metalloproteinase inhibitors and intermediates for preparation thereof |
| 06/24/2004 | WO2004022716A3 Recombinatant mutants of rhabdovirus and methods of use thereof |
| 06/24/2004 | WO2004014304A3 Electrospun amorphous pharmaceutical compositions |
| 06/24/2004 | WO2003099221A3 Methods for using jnk inhibitors for treating or preventing disease-related wasting |
| 06/24/2004 | WO2003092580B1 Methods and compositions for treatment of central and peripheral nervous system disorders and novel compounds useful therefor |
| 06/24/2004 | WO2003083083A3 Methods of using flt3-ligand in immunization protocols |
| 06/24/2004 | WO2003030656A3 Methods and compositions for promoting growth and innate immunity in young animals |
| 06/24/2004 | WO2002092594A8 Substituted 4h-chromenes and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 06/24/2004 | US20040122218 Pyrrolopyridine potassium channel openers |
| 06/24/2004 | US20040122125 Lactone compounds as novel photoinitiators |
| 06/24/2004 | US20040122052 Isoindolin-1-one and Isoindoline-1,3-dione substituted in the 2-position with a 2,6-dioxo-3-hydroxypiperidin-5-yl group or derivative; selectively inhibit TNF alpha, useful in treating inflammation and effecting relaxation of airway smooth muscle |
| 06/24/2004 | US20040122049 heterocyclic derivatives containing N-substituted piperidine ring and an amide or urea group; useful for treating rheumatic arthritis |
| 06/24/2004 | US20040122047 Substituted tetrahydroisoquinolines |
| 06/24/2004 | US20040122041 Oxazolo, thiazolo and selenazolo [4,5-c]-quinolin-4-amines and analogs thereof |
| 06/24/2004 | US20040122039 Pyrazolo[1,5-a]pyridines and medicines containing the same |
| 06/24/2004 | US20040122035 selective inhibitors of cyclic guanosine monophosphate (cGMP)-specific phosphodiesterase-5 (PDE5); sexual disorders, cardiovascular disorders; 1-(2H-benzo[d]1,3-dioxolan-5-yl)(1,2,3,4-tetrahydro- beta -carbolin-2-yl)-2-naphthyl ketone for example |
| 06/24/2004 | US20040122030 Substituted phthalimide and isoquinoline derivatives; thalidomide analogs that lack the piperidine-2,6-dione moiety of thalidomide |
| 06/24/2004 | US20040122023 Enantiomers of 1-[(4-chlorophenyl)phenylmethyl]-4-[(4-methylphenyl) sulfonyl] piperazine |
| 06/24/2004 | US20040122021 High optical purity of both levoratatory and dextrorotatory forms; simple, economic synthesis |
| 06/24/2004 | US20040122020 Novel amides, preparation and therapeutic use as modulators of ccr-receptor activity |
| 06/24/2004 | US20040122006 such as 7-[(2-aminophenyl)sulfanyl]-2H-1,4-benzoxazin-3(4H)-one; oxidation/reduction; deblocking/deprotectiing; cardiovascular disorders |
| 06/24/2004 | US20040121979 Pharmaceutically active uridine esters |
| 06/24/2004 | US20040121976 Anti-inflammatory vectors |
| 06/24/2004 | US20040121956 For therapy of diseases in animals and for the control of insects that are injurious or harmful to plants or animals |
| 06/24/2004 | US20040121944 Cyclosporin-based pharmaceutical compositions |
| 06/24/2004 | US20040121372 Comprises receptors for advanced glycation endproduct polypeptides for use in diagnosis and treatment inflammation, infection, sepsis, autoimmune, atherosclerotic and nervous system disorders |
| 06/24/2004 | US20040121345 Identification of a human n-terminal acetyltransferase gene |
| 06/24/2004 | US20040121325 Beta 1,2-xylosyltransferase-gene from arabidopsis |
| 06/24/2004 | US20040121028 Plant based agents as bioavailability / bioefficacy enhancers for drugs and nutraceuticals |
| 06/24/2004 | US20040120965 Method to reduce the physiologic effects of drugs on mammals |
| 06/24/2004 | US20040120960 initial dosing of a therapeutically effective amount of an LFA-1 antagonist, followed by a subsequent intermittent dosing of a therapeutically effective amount of an LFA-1 antagonist |
| 06/24/2004 | US20040120952 Anti-TNF antibodies and peptides of human tumor necrosis factor |
| 06/24/2004 | US20040120948 antibody or a functional fragment thereof that recognizes a human CD40 antigen present on the surface of human B cells, dendritic cells |
| 06/24/2004 | US20040120945 Cell surface molecule mediating cell adhesion and signal transmission |
| 06/24/2004 | US20040120936 Enhanced composition for treatment of obesity |
| 06/24/2004 | US20040120935 Genetically modified yt cell line and use thereof |
| 06/24/2004 | US20040120917 Cosmetic or dermopharmaceutical composition comprising an enzyme which is insoluble in an aqueous medium, as well as its uses |
| 06/23/2004 | EP1431391A2 Rantes mutants and therapeutic applications thereof |
| 06/23/2004 | EP1431310A1 RECOMBINANT ANTI−OSTEOPONTIN ANTIBODY AND USE THEREOF |
| 06/23/2004 | EP1431293A1 Water-soluble phenylpyridazine derivatives and drugs containing the same |
| 06/23/2004 | EP1431285A1 Reverse hydroxamic acid derivatives |
| 06/23/2004 | EP1431284A1 Diaryl sulfide derivative, addition salt thereof, and immunosuppressant |
| 06/23/2004 | EP1431275A1 Diaryl ether derivative, addition salt thereof, and immunosuppressant |
| 06/23/2004 | EP1430904A1 Desensitizers |
| 06/23/2004 | EP1430894A1 Lymphocytic activation inhibitor and remedial agent for autoimmune disease |
| 06/23/2004 | EP1430304A1 Method and agent for diagnosing and treating chronic inflammatory bowel diseases |
| 06/23/2004 | EP1430144A2 METHODS OF USING 69039, A NOVEL HUMAN Na/Ca EXCHANGER FAMILY MEMBER |
| 06/23/2004 | EP1430133A2 A soluble toll-like receptor |
| 06/23/2004 | EP1430130A2 Nucleic acid-associated proteins |
| 06/23/2004 | EP1430085A1 Leukocyte inactivation module |
| 06/23/2004 | EP1430084A2 Peptides capable of modulating immune response |
| 06/23/2004 | EP1430053A1 Chemical compounds |
| 06/23/2004 | EP1430050A1 Piperidine derivatives and their use as modulators of chemokine (especially ccr3) activity |
| 06/23/2004 | EP1430048A1 3-(arylamino)methylene-1, 3-dihydro-2h-indol-2-ones as kinase inhibitors |
| 06/23/2004 | EP1430042A2 Bicyclic heterocycles as rxr ligands |
| 06/23/2004 | EP1430041A2 Novel sulfonic acid derivatives |
| 06/23/2004 | EP1430027A2 Novel aminoazetidine, -pyrrolidine and -piperidine derivatives |
| 06/23/2004 | EP1429845A2 Treatment or prophylaxis of insulin-producing cell graft rejection |
| 06/23/2004 | EP1429842A2 Flavonoids for the treatment of diabetes |
| 06/23/2004 | EP1429806A2 Extracellular massengers |
| 06/23/2004 | EP1429804A2 Inhibitors of costimulation by ox40 and their use against infectious diseases |